Oncology

HR+/HER2- Metastatic Breast Cancer @ SABCS

Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2025

conference reporter by Angela M. DeMichele, MD, MSCE, FASCO; Sonya Reid, MD, MPH

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Metastatic Breast Cancer presented at the San Antonio Breast Cancer Symposium 2025.

VIEW THE TOPICS:

Disparities in Care for HR+/HER2- Breast Cancer
Liquid Biopsy for Defining Risk and Tailoring Treatment in Metastatic HR+/HER2- Breast Cancer
Recognizing and Managing Treatment-Related Toxicities in Metastatic HR+/HER2- Breast Cancer
Targeting Therapy Resistance in Metastatic HR+/HER2- Breast Cancer

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.

SABCS 2025

December 9–December 13, 2025

Henry B. Gonzalez Convention Center, San Antonio, TX & Online

Link to Registration

Profile

Angela M. DeMichele, MD, MSCE, FASCO

Co-Leader, Breast Cancer Research Program, Abramson Cancer Center
Co-Director, 2-PREVENT Breast Cancer Translational Center of Excellence
Director, Clinical/Translational Research in Solid Oncology, Division of Hematology/Oncology
Professor, Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA

Profile

Sonya Reid, MD, MPH

Associate Professor of Medicine
Division of Hematology and Oncology
Assistant Director of Community Outreach and Engagement
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, TN